Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

PET imaging with multimodal upconversion nanoparticles.

Gallo J, Alam IS, Jin J, Gu YJ, Aboagye EO, Wong WT, Long NJ.

Dalton Trans. 2014 Apr 14;43(14):5535-45. doi: 10.1039/c3dt53095g. Epub 2014 Feb 18.

PMID:
24535647
2.

In vivo evaluation of a radiogallium-labeled bifunctional radiopharmaceutical, Ga-DOTA-MN2, for hypoxic tumor imaging.

Sano K, Okada M, Hisada H, Shimokawa K, Saji H, Maeda M, Mukai T.

Biol Pharm Bull. 2013;36(4):602-8.

3.

PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.

Lee HY, Li Z, Chen K, Hsu AR, Xu C, Xie J, Sun S, Chen X.

J Nucl Med. 2008 Aug;49(8):1371-9. doi: 10.2967/jnumed.108.051243. Epub 2008 Jul 16.

4.

Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.

Lopez-Rodriguez V, Gaspar-Carcamo RE, Pedraza-Lopez M, Rojas-Calderon EL, Arteaga de Murphy C, Ferro-Flores G, Avila-Rodriguez MA.

Nucl Med Biol. 2015 Feb;42(2):109-14. doi: 10.1016/j.nucmedbio.2014.09.010. Epub 2014 Oct 5.

PMID:
25316595
5.

(44)Sc: an attractive isotope for peptide-based PET imaging.

Hernandez R, Valdovinos HF, Yang Y, Chakravarty R, Hong H, Barnhart TE, Cai W.

Mol Pharm. 2014 Aug 4;11(8):2954-61. doi: 10.1021/mp500343j. Epub 2014 Jul 23.

6.

PET imaging of CXCR4 receptors in cancer by a new optimized ligand.

Demmer O, Gourni E, Schumacher U, Kessler H, Wester HJ.

ChemMedChem. 2011 Oct 4;6(10):1789-91. doi: 10.1002/cmdc.201100320. Epub 2011 Jul 20. No abstract available.

7.

Bioorthogonal chemistry for (68) Ga radiolabelling of DOTA-containing compounds.

Evans HL, Carroll L, Aboagye EO, Spivey AC.

J Labelled Comp Radiopharm. 2014 Apr;57(4):291-7. doi: 10.1002/jlcr.3153. Epub 2013 Dec 5.

PMID:
24307493
8.

Ultrasmall particles for Gd-MRI and (68) Ga-PET dual imaging.

Truillet C, Bouziotis P, Tsoukalas C, Brugière J, Martini M, Sancey L, Brichart T, Denat F, Boschetti F, Darbost U, Bonnamour I, Stellas D, Anagnostopoulos CD, Koutoulidis V, Moulopoulos LA, Perriat P, Lux F, Tillement O.

Contrast Media Mol Imaging. 2015 Jul-Aug;10(4):309-19. doi: 10.1002/cmmi.1633. Epub 2014 Dec 5.

PMID:
25483609
9.

PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.

Roosenburg S, Laverman P, Joosten L, Cooper MS, Kolenc-Peitl PK, Foster JM, Hudson C, Leyton J, Burnet J, Oyen WJ, Blower PJ, Mather SJ, Boerman OC, Sosabowski JK.

Mol Pharm. 2014 Nov 3;11(11):3930-7. doi: 10.1021/mp500283k. Epub 2014 Jul 11.

PMID:
24992368
10.

Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model.

Ujula T, Huttunen M, Luoto P, Peräkylä H, Simpura I, Wilson I, Bergman M, Roivainen A.

Bioconjug Chem. 2010 Sep 15;21(9):1612-21. doi: 10.1021/bc1000643.

PMID:
20795647
11.

Gallium-68 complex of a macrobicyclic cage amine chelator tethered to two integrin-targeting peptides for diagnostic tumor imaging.

Ma MT, Neels OC, Denoyer D, Roselt P, Karas JA, Scanlon DB, White JM, Hicks RJ, Donnelly PS.

Bioconjug Chem. 2011 Oct 19;22(10):2093-103. doi: 10.1021/bc200319q. Epub 2011 Sep 27.

PMID:
21877750
12.

(64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.

Li ZB, Cai W, Cao Q, Chen K, Wu Z, He L, Chen X.

J Nucl Med. 2007 Jul;48(7):1162-71. Epub 2007 Jun 15.

13.

Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK).

Simeček J, Notni J, Kapp TG, Kessler H, Wester HJ.

Mol Pharm. 2014 May 5;11(5):1687-95. doi: 10.1021/mp5000746. Epub 2014 Apr 4.

PMID:
24669840
14.

In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.

Roosenburg S, Laverman P, Joosten L, Eek A, Rutjes FP, van Delft FL, Boerman OC.

Mol Imaging. 2012 Sep-Oct;11(5):401-7.

PMID:
22954184
15.

Radiolabelling DOTA-peptides with 68Ga.

Breeman WA, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP.

Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):478-85. Epub 2005 Jan 18.

PMID:
15655678
16.

PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates.

Beaino W, Anderson CJ.

J Nucl Med. 2014 Nov;55(11):1856-63. doi: 10.2967/jnumed.114.144881. Epub 2014 Sep 25.

17.

(68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.

Liu Z, Niu G, Shi J, Liu S, Wang F, Liu S, Chen X.

Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):947-57. doi: 10.1007/s00259-008-1045-1. Epub 2009 Jan 22.

PMID:
19159928
18.

(68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.

Liu Z, Niu G, Wang F, Chen X.

Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1483-94. doi: 10.1007/s00259-009-1123-z. Epub 2009 Apr 10.

PMID:
19360404
19.

Radiogallium Complex-Conjugated Bifunctional Peptides for Detecting Primary Cancer and Bone Metastases Simultaneously.

Ogawa K, Yu J, Ishizaki A, Yokokawa M, Kitamura M, Kitamura Y, Shiba K, Odani A.

Bioconjug Chem. 2015 Aug 19;26(8):1561-70. doi: 10.1021/acs.bioconjchem.5b00186. Epub 2015 Jul 2.

PMID:
26087328
20.

Ligands for mapping alphavbeta3-integrin expression in vivo.

Schottelius M, Laufer B, Kessler H, Wester HJ.

Acc Chem Res. 2009 Jul 21;42(7):969-80. doi: 10.1021/ar800243b.

PMID:
19489579

Supplemental Content

Support Center